PNP

Truecanhelp Unveils New CRS Score Calculator to Enhance the Canadian Immigration Process

Retrieved on: 
星期五, 四月 26, 2024
Express Entry, Education, CRS, PNP, Online shopping

Innovative Tool Designed to Help Prospective Immigrants Assess Their Eligibility for Express Entry

Key Points: 
  • The CRS Score Calculator by Truecanhelp is developed to provide immediate feedback on an applicant's Comprehensive Ranking System (CRS) score, considering various factors such as age, education, language proficiency, work experience, and eligibility under programs like the Provincial Nominee Program (PNP) .
  • With the introduction of the CRS Score Calculator, applicants can quickly determine their CRS scores, allowing them to understand better their standing in the pool of candidates for immigration.
  • The CRS Score Calculator not only enhances the user experience but also reflects Truecanhelp's dedication to fostering a supportive and efficient immigration process.
  • For more information about the CRS Score Calculator and to explore Truecanhelp's comprehensive range of immigration services, please visit Truecanhelp's website .

Supermicro Announces Third Quarter Fiscal Year 2024 Financial Results

Retrieved on: 
星期二, 四月 30, 2024
Apps, Applications, Technology, 5G, Telecommunications, Software, Networks, Internet, Hardware, Data Management, Artificial Intelligence, Cloud, Table, Total, Annual report, Security (finance), PNP, Webcast, Public expenditure, DLC, Risk, EPS, GAAP, Growth

Gross margin of 15.5% versus 15.4% in the second quarter of fiscal year 2024 and 17.6% in the same quarter of last year.

Key Points: 
  • Gross margin of 15.5% versus 15.4% in the second quarter of fiscal year 2024 and 17.6% in the same quarter of last year.
  • Net income of $402 million versus $296 million in the second quarter of fiscal year 2024 and $86 million in the same quarter of last year.
  • Diluted net income per common share of $6.56 versus $5.10 in the second quarter of fiscal year 2024 and $1.53 in the same quarter of last year.
  • Non-GAAP diluted net income per common share of $6.65 versus $5.59 in the second quarter of fiscal year 2024 and $1.63 in the same quarter of last year.

Supermicro CEO Charles Liang to Once Again Deliver CEO Keynote at COMPUTEX 2024

Retrieved on: 
星期二, 四月 30, 2024
Cloud, AMD, Total, Green computing, AI, Taipei Nangang Exhibition Center, PNP, Electricity, TCO, Carbon footprint, NVIDIA, Memory, Edge computing, Generative, Building block, COMPUTEX, Graphics processing unit, Liquid cooling, Byton (company), Growth, Green, Video game

SAN JOSE, Calif. and TAIPEI, April 30, 2024 /PRNewswire/ -- Supermicro, Inc. (NASDAQ: SMCI), a Total IT Solution Provider for AI, Cloud, Storage, and 5G/Edge, announced that for the seventh consecutive year, President and CEO, Charles Liang will present a CEO Keynote at COMPUTEX 2024, one of the most significant computing and technology events focused on the theme of 'Connecting AI' in Taipei from June 4 to 7, 2024. The Supermicro CEO keynote will be on Wednesday, June 5, at 9:30 AM at Taipei Nangang Exhibition Center Hall 2, 7F (or online).

Key Points: 
  • The Supermicro CEO keynote will be on Wednesday, June 5, at 9:30 AM at Taipei Nangang Exhibition Center Hall 2, 7F (or online).
  • "Supermicro continues to drive the growth of Generative AI Technologies by pushing boundaries and building innovative energy efficient solutions across the spectrum from data centers to intelligent edge," said Charles Liang, president and CEO of Supermicro.
  • Supermicro is thrilled to be a part of COMPUTEX 2024 and to showcase these innovations and capabilities."
  • CEO Keynote will take place in-person on Wednesday, June 5 at 9:30 AM at Taipei Nangang Exhibition Center Hall 2, 7F (or online).

Supermicro CEO Charles Liang to Once Again Deliver CEO Keynote at COMPUTEX 2024

Retrieved on: 
星期二, 四月 30, 2024
Cloud, AMD, Total, Green computing, AI, Taipei Nangang Exhibition Center, PNP, Electricity, TCO, Carbon footprint, NVIDIA, Memory, Edge computing, Generative, Building block, COMPUTEX, Graphics processing unit, Liquid cooling, Byton (company), Growth, Green, Video game

SAN JOSE, Calif. and TAIPEI, April 30, 2024 /PRNewswire/ -- Supermicro, Inc. (NASDAQ: SMCI), a Total IT Solution Provider for AI, Cloud, Storage, and 5G/Edge, announced that for the seventh consecutive year, President and CEO, Charles Liang will present a CEO Keynote at COMPUTEX 2024, one of the most significant computing and technology events focused on the theme of 'Connecting AI' in Taipei from June 4 to 7, 2024. The Supermicro CEO keynote will be on Wednesday, June 5, at 9:30 AM at Taipei Nangang Exhibition Center Hall 2, 7F (or online).

Key Points: 
  • The Supermicro CEO keynote will be on Wednesday, June 5, at 9:30 AM at Taipei Nangang Exhibition Center Hall 2, 7F (or online).
  • "Supermicro continues to drive the growth of Generative AI Technologies by pushing boundaries and building innovative energy efficient solutions across the spectrum from data centers to intelligent edge," said Charles Liang, president and CEO of Supermicro.
  • Supermicro is thrilled to be a part of COMPUTEX 2024 and to showcase these innovations and capabilities."
  • CEO Keynote will take place in-person on Wednesday, June 5 at 9:30 AM at Taipei Nangang Exhibition Center Hall 2, 7F (or online).

Festo's smart proximity switch commissions itself, for time savings that add up

Retrieved on: 
星期四, 四月 11, 2024
Proline, CNC, Normality (behavior), PNP, Festo, Polymer, NPN, Logic, Multimedia, PLC, Perspiration, Material

MISSISSAUGA, ON, April 11, 2024 /PRNewswire-PRWeb/ -- There are indeed rewards for machine builders who sweat the small stuff. The latest iterations of many tiny but essential components like sensors, cameras and switches can pack a great deal of innovation for their diminutive size.

Key Points: 
  • With many proximity switches on each Pro-Line machine, the time savings from no longer having to make this follow-up adjustment really add up.
  • This feature-rich proximity switch is one example of the advances Festo is making in designing next-generation components, large or small.
  • Proximity switches are affixed to pneumatic actuators to signal the PLC or controller that the full extension of the piston has been reached.
  • However, with vinyl or polymers that have some give, a soft stop can be a challenge for a legacy switch.

Evidence review: Maternal mental conditions drive climbing death rate in U.S.

Retrieved on: 
星期三, 二月 21, 2024
Mental health, Woman, PNP, Suicide, Infection, Prenatal development, Hospital, Public health, Bleeding, MPA, Fatality, Maternal death, Mental, DSM-IV codes, Pregnancy, Communication, Death, Internal bleeding, Risk, Health, JAMA Psychiatry, FACOG, University, Infant, Disease, Mother, White, Health policy, Maternal health, Child, Mortality, Drug overdose, George Washington University, Research, Medicine, Depression

“The contribution of mental health conditions to the maternal morbidity and mortality crisis that we have in America is not widely recognized,” said Katherine L. Wisner, M.D.

Key Points: 
  • “The contribution of mental health conditions to the maternal morbidity and mortality crisis that we have in America is not widely recognized,” said Katherine L. Wisner, M.D.
  • , associate chief of Perinatal Mental Health and member of the Center for Prenatal, Neonatal & Maternal Health Research at Children’s National.
  • Overdose and other maternal mental health conditions are taking the lives of more than twice as many women as postpartum hemorrhage, the second leading cause of maternal death.
  • Mental health conditions such as suicide or opioid overdose are to blame for nearly 23% of maternal deaths in America, according to reports from three dozen Maternal Morbidity and Mortality Review Committees, which are state-based organizations that review each maternal death within a year of pregnancy.

Balluff Offers Simplified I/O Hubs with Lightweight, Sustainable Housings

Retrieved on: 
星期二, 二月 6, 2024
IO-Link, Multimedia, Robotics, Vibration, NPN, Shock, Housing, Temperature, Documentation, PNP, IP67, Video game

FLORENCE, Ky., Feb. 6, 2024 /PRNewswire-PRWeb/ -- Companies wanting to add IO-Link to their production have a new option – Balluff's simplified I/O hubs.

Key Points: 
  • FLORENCE, Ky., Feb. 6, 2024 /PRNewswire-PRWeb/ -- Companies wanting to add IO-Link to their production have a new option – Balluff's simplified I/O hubs.
  • Balluff's simplified I/O hubs provide fast, effective signal transmission and reduced signal runtimes.
  • An extension of Balluff's broad IO-Link portfolio, these new networking blocks offer simple handling and basic I/O functions in compact, lightweight, and sustainable housing.
  • Designed with deliberate simplicity, these new hubs deliver I/O functions without complex add-ons that aren't needed for some applications.

NuMLM: Hologram Sciences' New AI-Powered Solution Targeting Clinical Malnutrition

Retrieved on: 
星期二, 二月 6, 2024
Health, Technology, Hospitals, Health Technology, Fitness & Nutrition, Managed Care, Artificial Intelligence, Multimedia, Mayo Clinic, Science, Malnutrition, Patient, PNP, Food, Database, Risk, Nursing

NuMLM addresses the large-scale challenge of correctly assessing individual patient nutrition, a widely documented and operationally intensive obstacle to optimizing patient outcomes.

Key Points: 
  • NuMLM addresses the large-scale challenge of correctly assessing individual patient nutrition, a widely documented and operationally intensive obstacle to optimizing patient outcomes.
  • NuMLM's precise and timely tracking of patients' nutritional intake is essential for the PNP to suggest appropriate interventions and alert clinical staff.
  • Ian Brady, CEO of Hologram Sciences, stated, 'We're addressing a critical gap in patient care and applying AI to a clinical need that will dramatically benefit from personalization at scale.
  • Brady added, “Our aim is to apply advanced technology to widespread clinical needs, serving people's wellbeing first and foremost.

Sirnaomics to Present Latest Developments of STP705 for Focal Fat Reduction at IMCAS World Congress 2024

Retrieved on: 
星期一, 二月 5, 2024
Poster, FFR, Plastic surgery, Division, Clinical trial, Therapy, Safety, PNP, RNA interference, University of Miami, Phase, University, Conference

and SUZHOU, China, Feb. 5, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, presented the latest developments on Polypeptide Nanoparticle (PNP) platform, and its pipeline program STP705 for Focal Fat Reduction's positive clinical data, at IMCAS World Congress 2024, which is taking place in Paris from February 1st - 3rd, 2024.

Key Points: 
  • and SUZHOU, China, Feb. 5, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, presented the latest developments on Polypeptide Nanoparticle (PNP) platform, and its pipeline program STP705 for Focal Fat Reduction's positive clinical data, at IMCAS World Congress 2024, which is taking place in Paris from February 1st - 3rd, 2024.
  • Previously, Sirnaomics had reported that a poster with positive clinical data of STP705 for focal fat reduction (FFR) was presented at the 2023 Fall Clinical Dermatology Conference.
  • The safety and efficacy results of this Phase I study support further investigation of STP705 as a potential alternative to other injectables for FFR.
  • The positive data from the Phase I clinical study has led to the Group advancing the program to the Phase II clinical study stage.

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings

Retrieved on: 
星期日, 一月 7, 2024
Biotechnology, Health, Genetics, Pharmaceutical, Clinical Trials, SCD, Kingdom, Blue Shield, Conference, T1D, Sickle cell disease, Gene editing, Blue Cross, Pain, Messenger, EMA, FDA, PDUFA, Cystic fibrosis, Insulin, Vertex Pharmaceuticals, Abdominoplasty, European Medicines Agency, Sciatica, SAD, PNP, Glycated hemoglobin, Patient, TDT, Safety, Diabetes, Acceleration, Hypoglycemia, CFTR, VRTX, CHMP, Pharmaceutical industry

Epidemiology update: Vertex revised its estimates for the number of patients living with cystic fibrosis from ~88,000 to ~92,000 in the U.S., Europe, Australia, and Canada.

Key Points: 
  • Epidemiology update: Vertex revised its estimates for the number of patients living with cystic fibrosis from ~88,000 to ~92,000 in the U.S., Europe, Australia, and Canada.
  • The FDA has assigned a Prescription Drug User Fee Act (PDUFA) action date of March 30, 2024, for CASGEVY in TDT.
  • VX-993: Vertex also anticipates initiating a Phase 2 study with an oral formulation of VX-993 for the treatment of PNP in 2024.
  • A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com , in the "Investors" section under the "News and Events" page.